Abbott's Absorb dissolving heart stent proved as safe and effective one year after being placed in a diseased artery as the company's market-leading Xience drug coated metal stent with a significantly lower rate of chest pain, according to data presented at a medical meeting on Sunday. Absorb works in the same way as traditional heart stents, propping open arteries that have been cleared of blockages to restore normal blood flow. The most notable difference observed after one year in the European study was the rate of angina, a type of chest pain associated with diminished blood flow to the heart. "The lower rate of chest pain observed in people treated with Absorb is a promising finding that shows that Absorb may offer people unique quality of life benefits beyond the excellent clinical outcomes already offered with drug eluting stents," Dr. Patrick Serruys, the study's lead investigator who presented the data at the Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, said in a statement. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment